List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 101 studies with search of:   Open Studies | "Gliosarcoma"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Temozolomide;   Radiation: Radiation;   Drug: Sorafenib
2 Recruiting Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Avastin;   Drug: Tarceva;   Drug: Temodar
3 Recruiting Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas
Conditions: Glioblastoma;   Gliosarcoma;   Brain Tumor
Intervention: Drug: Avastin, radiation, temozolomide, and irinotecan
4 Recruiting Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temozolomide (Temodar)
5 Recruiting Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Conditions: Gliosarcoma;   Glioblastoma
Intervention: Drug: Vandetanib and Etoposide
6 Recruiting Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Avastin and Bortezomib
7 Recruiting Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Bevacizumab and Etoposide
8 Recruiting A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
Interventions: Other: Taking EIAEDs (enzyme-inducing anticonvulsant medications);   Other: NOT taking EIAEDs
9 Recruiting Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Zactima, Gleevec, Hydroxyurea
10 Not yet recruiting Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Glioma
Interventions: Other: enzyme-inducing anti-epileptic drugs;   Other: enzyme-inducing anti-epileptic drugs
11 Recruiting Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Bevacizumab and Erlotinib
12 Recruiting Ph I Trial of Oral Topotecan + Temozolomide in Treatment of Pts w Malignant Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma
Intervention: Drug: Temodar and Topotecan
13 Recruiting Ph I Dasatinib + Erlotinib in Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Erlotinib and Dasatinib
14 Recruiting Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Erlotinib, Sirolimus
15 Recruiting Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: erlotinib hydrochloride;   Drug: sorafenib tosylate;   Drug: temsirolimus;   Drug: tipifarnib
16 Recruiting Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab;   Drug: erlotinib hydrochloride;   Drug: temozolomide;   Procedure: adjuvant therapy
17 Recruiting Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: radiation therapy
18 Not yet recruiting Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab;   Drug: erlotinib hydrochloride;   Drug: temozolomide;   Procedure: 3-dimensional conformal radiation therapy;   Procedure: adjuvant therapy;   Procedure: intensity-modulated radiation therapy
19 Recruiting Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: motexafin gadolinium;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: radiation therapy
20 Not yet recruiting Temozolomide, Carmustine, O6-Benzylguanine, Radiation Therapy, and an Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: carmustine;   Drug: temozolomide;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services